Eventide Asset Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Eventide Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$446.73 - $548.2 $13.8 Million - $16.9 Million	-30,900 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$336.18 - $494.43 $10.4 Million - $15.3 Million	30,900 New	30,900 $15.1 Million
Q4 2018 Feb 14, 2019	SELL	$335.82 - $403.04 $7.72 Million - $9.27 Million	-23,000 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$315.82 - $393.78 $4.9 Million - $6.1 Million	15,500 Added 206.67%	23,000 $7.92 Million
Q3 2017 Nov 14, 2017	BUY	$431.38 - $504.0 $3.24 Million - $3.78 Million	7,500	7,500 $3.35 Million

1,534

83.8M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $83.4B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Eventide Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Eventide Asset Management, LLC with notifications on news.